The Effects of Trans-Resveratrol (RSV) on Insulin Resistance, Inflammation, and the Metabolic Syndrome: A Placebo Controlled, Double-Blind Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Resveratrol (Primary)
- Indications Hypertension; Hypertriglyceridaemia; Insulin resistance; Low HDL cholesterol; Obesity
- Focus Biomarker; Therapeutic Use
- 24 Oct 2018 Biomarkers information updated
- 30 Nov 2012 New trial record